Bergenin hinders the production of extracellular matrix in glomerular mesangial cells and mitigates diabetic nephropathy in mice by suppressing oxidative stress through the mTOR/β-TrcP/Nrf2 pathway [40]. Here, MTOR is linked to diabetic kidney disease.